B4
For more than two years Northern Ireland has faced difficulties trading with the wider UK. The 2020 Northern Ireland Protocol established systems for trade in and out of Northern Ireland, but has led to a mass of practical difficulties both in the flow of goods across the Irish Sea, and legal compliance for businesses operating […]
The Competition and Markets Authority (the CMA) has recently published for consultation draft guidance as to how competition laws apply to environmental sustainability agreements.
A new approach to the use of precision genetic technology in plants and animals has recently been introduced in England. This will make is easier to use advanced DNA editing methods like CRISPR-Cas9 in the agrifood sector.
Universities and spin-out companies should be reviewing their general position in relation to intellectual property ownership in light of the court’s decision in the recent case of Oxford University Innovations v Oxford Nanoimaging 2022.
The EU Clinical Trials Regulation (EU) 536/2014 (the CTR) became applicable on 31 January 2022. We asked our best friend firm in Germany, Graf von Westphalen, to give us an insight into how the CTR and the related Clinical Trials Information System (CTIS) are bedding in.
A recent ABPI report highlighted a decline in UK clinical trials. Improving the UK ecosystem for clinical research will involve a range of measures, and we look forward to publication of the O’Shaughnessy review. This sits alongside an ongoing substantial upgrade to UK clinical trials legislation and guidance, that forms the focus of this article.
As Culham Innovation Centre in south Oxfordshire celebrates 22 years of providing flexible workspace for innovators in the science sector, the innovation centre is also reflecting on its contribution to cutting-edge technology that is helping to deliver potentially world-changing solutions.
Oxford Innovation Space manages the largest network of innovation centres across the UK, managing 25 centres currently with a further seven in the pipeline. With the scale and pace of growth, Oxford Innovation Space has taken the strategic decision to divide its business development portfolio into public sector clients and science and technology clients, creating new senior roles to set the benchmark and continue the growth trajectory.
Businesses, university departments and research groups will once again gather in the unique setting of Abingdon’s historic Market Place for the ATOM Festival “Science Market” on 11th March.
Biotech start-up Samsara Therapeutics, an early-stage drug discovery company, has expanded into a further 1,000 sq ft of R&D lab space at The Oxford Trust’s Wood Centre for Innovation in Headington, Oxford’s Health and Life Sciences District to accommodate company growth.
Kick-start opportunity for a science-based start-up to benefit from over £10k of lab and business support for one-year at Oxfordshire’s Heyford Park Innovation centre. Biotech start-ups are invited to enter a competition to win a 12-month lab space and business support package at Heyford Park Innovation Centre (HPIC) in Oxfordshire. The prize, which is worth […]
A new £1.4M grant will fund a five-year research project by scientists at Oxford Brookes University. Funded by the Biotechnology and Biological Sciences Research Council (BBSRC), the grant will also create three new roles, and new opportunities for PhD students.
The latest news from the Life Sciences sector, from medical innovation to start-ups and funding. Featuring B4 Members Owen Mumford, Partners&, Oxford North, Penningtons Manches Cooper and many more.